| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.406 | 10.929 | 15.964 | 14.089 | 21.693 | 13.557 | 27.843 | 52.054 | 43.827 | 21.289 |
| Total Income - EUR | 7.406 | 10.929 | 15.964 | 14.089 | 21.693 | 13.939 | 27.843 | 52.054 | 43.827 | 21.289 |
| Total Expenses - EUR | 6.819 | 10.483 | 14.603 | 21.526 | 20.381 | 13.491 | 17.763 | 32.068 | 37.229 | 35.811 |
| Gross Profit/Loss - EUR | 587 | 446 | 1.361 | -7.438 | 1.312 | 448 | 10.081 | 19.986 | 6.598 | -14.522 |
| Net Profit/Loss - EUR | 364 | 118 | 1.088 | -7.579 | 1.096 | 313 | 9.802 | 19.214 | 6.160 | -14.580 |
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Vaximfan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.373 | 11.918 | 37.863 | 31.240 | 24.822 | 19.089 | 13.089 | 50.434 | 33.705 | 20.791 |
| Current Assets | 3.779 | 6.033 | 4.696 | 3.848 | 5.441 | 2.946 | 3.682 | 4.399 | 10.277 | 9.003 |
| Inventories | 3.204 | 3.357 | 4.356 | 2.137 | 327 | 49 | 2.928 | 1.644 | 3.587 | 4.410 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 575 | 2.676 | 340 | 1.711 | 5.114 | 2.896 | 753 | 2.755 | 6.690 | 4.593 |
| Shareholders Funds | -26.498 | -26.109 | -24.579 | -31.707 | -29.997 | -29.116 | -18.667 | 488 | 6.647 | -7.970 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 42.649 | 44.060 | 67.138 | 66.795 | 60.260 | 51.150 | 35.438 | 54.345 | 37.335 | 37.764 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Vaximfan Srl